Doxycycline or minocycline may be a viable treatment option against SARS-CoV-2
- PMID: 32758890
- PMCID: PMC7320853
- DOI: 10.1016/j.mehy.2020.110054
Doxycycline or minocycline may be a viable treatment option against SARS-CoV-2
Keywords: COVID-19; Doxycycline; Minocycline; SARS-CoV-2; Tetracyclines.
References
-
- World Health Organization: Coronavirus disease 2019 (COVID-19) Situation Report – 153. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... Date: June 21, 2020 Date accessed: June 22, 2020.
-
- Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239. doi: 10.1001/jama.2020.2648. [Epub ahead of print] - DOI - PubMed
-
- Michaelis M., Kleinschmidt M.C., Doerr H.W., Cinatl J., Jr. Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells. J Antimicrob Chemother. 2007;2007(60):981–986. - PubMed
-
- Rothan Hussin A., Mohamed Zulqarnain, Paydar Mohammadjavad, Rahman Noorsaadah Abd, Yusof Rohana. Inhibitory effect of doxycycline against dengue virus replication in vitro. Arch Virol. 2014;159:711–718. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
